161 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
GWPH GW Pharmaceuticals Plc $115.31 $2.93B Sell
Article Searches
Your Daily Pharma Scoop: Dynavax Achieves Major Milestone, GW Pharmaceuticals GWP42006 Fails, Sangamo Signs Deal With Gilead's Kite Unit https://seekingalpha.com/article/4149469-daily-pharma-scoop-dynavax-achieves-major-milestone-gw-pharmaceuticals-gwp42006-fails-sangamo?source=feed_sector_healthcare Feb 23, 2018 - Dynavax’s commercialization efforts with HEPLISAV-B get a boost.GW Pharmaceuticals’ GWP42006 fails in proof-of-concept study.Sangamo inks a deal with Gilead’s Kite Pharma unit.
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2017 Update https://seekingalpha.com/article/4149426-tracking-ole-andreas-halvorsens-viking-global-portfolio-q4-2017-update?source=feed_all_articles Feb 22, 2018 - Halvorsen's 13F portfolio value increased from $15.44B to $16.26B. The number of positions remained steady at 59.Viking Global increased Anthem, Parsley Energy, and Domino’s Pizza while reducing Alpha
U.S. Biotech/Pharma Sector Daily Observations Letter: February 21, 2018 https://seekingalpha.com/article/4149259-u-s-biotech-pharma-sector-daily-observations-letter-february-21-2018?source=feed_sector_healthcare Feb 22, 2018 - Whipsaw day with the sharp move down at the close making market direction unclear. GW Pharma’s (GWPH) cannabinoid drug GWP42006 (cannabidivarin, CBDV) failed to meet the endpoints in a phase 2a study
269 Marijuana Stocks: Correction, Crash, Or Slow Descent? https://seekingalpha.com/article/4149221-269-marijuana-stocks-correction-crash-slow-descent?source=feed_all_articles Feb 21, 2018 - I have been on the planet for 60+ years, and this is starting to look more like a general market “crash” than a “correction”.The first rule I was taught pre-1980 as an undergraduate student was “don’t
Marijuana Stocks That Could Outpace The Market In 2018 https://seekingalpha.com/article/4148555-marijuana-stocks-outpace-market-2018?source=feed_all_articles Feb 20, 2018 - Private and public funds are throwing tens of million of dollars in anticipation of several industry catalysts that will be seen in 2018.New ETFs are coming online that are heavily investing in top co
Your Daily Pharma Scoop: GW Pharmaceuticals Pullback, Seattle Genetics Announces Collaboration Agreement, Catalyst Reports Data https://seekingalpha.com/article/4145334-daily-pharma-scoop-gw-pharmaceuticals-pullback-seattle-genetics-announces-collaboration?source=feed_sector_healthcare Feb 10, 2018 - GW Pharmaceuticals looks attractive following recent pullback.Seattle Genetics has entered into a collaboration and license agreement with Pieris Pharmaceuticals.Catalyst Bioscience announced topline
Granite Point Capital Management, L.p. Buys GW Pharmaceuticals PLC, Zogenix Inc, Sage ... http://www.gurufocus.com/news/638121/granite-point-capital-management-lp-buys-gw-pharmaceuticals-plc-zogenix-inc-sage-therapeutics-inc-sells-himax-technologies-inc-mindbody-inc-advanced-micro-devices-inc Feb 08, 2018 - Granite Point Capital Management, L.p. Buys GW Pharmaceuticals PLC, Zogenix Inc, Sage Therapeutics Inc, Sells Himax Technologies Inc, MINDBODY Inc, Advanced Micro Devices Inc, Stocks: ZGNX,NTES,GOOGL,CEVA,GOOS,AXTI,GWPH,SAGE,WNC,CDNA,, release date:Feb 08, 2018
Hottest U.S. Marijuana ETF Risks Facing Closure https://seekingalpha.com/article/4144429-hottest-u-s-marijuana-etf-risks-facing-closure?source=feed_all_articles Feb 08, 2018 - ETFMG Alternative Harvest ETF is the only U.S. marijuana fund.Recent report indicates the ETF's custodian, Bancorp, is considering dropping the fund due to legal concerns.We think the risk is remote a
268 Marijuana Stocks: Learn From An Examination Of Event Dates For The Prior 52 Weeks https://seekingalpha.com/article/4144098-268-marijuana-stocks-learn-examination-event-dates-prior-52-weeks?source=feed_all_articles Feb 07, 2018 - The DOW was down 8.5% from record highs at the close on Monday, February 5, 2018; the public watches and reacts to the DOW.A partial recovery occurred on Tuesday, February 6, 2018; I started capturing
Your Daily Pharma Scoop: Nabriva Pullback, GW Pharmaceuticals Makes Progress, ContraVir Announces Promising Results https://seekingalpha.com/article/4143836-daily-pharma-scoop-nabriva-pullback-gw-pharmaceuticals-makes-progress-contravir-announces?source=feed_sector_healthcare Feb 07, 2018 - Nabriva has a major catalyst coming up. GW Pharmaceuticals’ marketing application for Epidiolex accepted by EMA. ContraVir announces results from early stage study of Hep B candidate TXL.

Pages: 123456...17

Page 1>

Related Companies

Name Exchange Price Mkt Cap
GBT Global Blood Therapeutics, Inc. NASDAQ $62.85 $2.91B
ANAB AnaptysBio, Inc. NASDAQ $123.12 $2.89B
PTLA Portola Pharmaceuticals, Inc. NASDAQ $45.82 $2.99B
CLVS Clovis Oncology, Inc. NASDAQ $56.84 $2.86B
LGND Ligand Pharmaceuticals Incorporated NASDAQ $153.81 $3.25B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for GW Pharmaceuticals Plc
GWPH - Google Finance https://www.google.com/finance?q=GWPH Industry related info and international coverage Summary News
GWPH - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=GWPH Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options